🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to verify the efficacy of ASP015K versus pl...
Status
Completed
Location
JP00037
Start Date
2014-07-25
Trial ID
NCT02305849
Treatments Being Tested
The primary objective is to compare the safety and efficacy of multiple dos...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01960855
PLX3397 is a selective inhibitor of Fms and Kit activity. The objective of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01090570
Treatments Being Tested
This study is designed to compare the effectiveness of the experimental dru...
Status
Completed
Location
Catalina Pointe Clinical Research, Inc.
Start Date
2010-01
Trial ID
NCT01039688
Treatments Being Tested
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
"Wait \& see" is currently the standard of care of recently diagnosed desmo...
Status
Recruiting
Location
Service d'oncologie/CHU de Besançon
Start Date
2024-03-04
Trial ID
NCT06081400
Treatments Being Tested
This is a randomized, double-blind, parallel group, 3 dosage level, placebo...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-01-24
Trial ID
NCT03028467
Treatments Being Tested
The objective of this study is to assess the safety and efficacy of Tacroli...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02660684
Treatments Being Tested
* Participants suffering from active rheumatoid arthritis who had an inadeq...
Status
Completed
Location
Artho Care, Arthritis Care & Research P.C.
Start Date
2013-10-08
Trial ID
NCT01894516
This research study is studying if the investigational drug, Pembrolizumab,...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2024-10-18
Trial ID
NCT06475235
Treatments Being Tested